期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

超敏C反应蛋白对不稳定型心绞痛预后的判断价值 被引量：1

在线阅读 下载PDF
导出
摘要 炎症在冠状动脉粥样硬化、斑块破裂和血栓形成中发挥重要作用。随着技术进步,目前传统炎症指标之一的C反应蛋白检测已经可达0.1mg/L以下,被称为超敏C-反应蛋白（hsCRP）,在心血管疾病的早期诊断和评估心血管病风险和心血管病死率方面的应用价值已经获得公认[1]。hs-CRP在冠脉综合征（ACS）时明显升高,并与心肌梗死病死率密切相关。
作者 操良会
机构地区 重庆市长寿区中医院检验科
出处 《国际检验医学杂志》 CAS 2014年第20期2859-2861,共3页 International Journal of Laboratory Medicine
关键词 不稳定型心绞痛 C反应蛋白 炎症指标 心血管疾病 斑块破裂 判断价值 技术进步 危险分层 蛋白检测 冠脉炎症
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献8

  • 1Rifai N, Ridker PM. High-sensitivity C-reactive protein: a noveland promising marker of coronary heart disease [J]. Clin Chem,2001,47(3):403-411.
  • 2Antman EM,Cohen M,Bernink PJ?et al. The TIMI risk score forunstable angina/non-ST elevation MI: A method for prognostica-tion and therapeutic decision making [J]. JAMA, 2000, 284 ( 7):835-842.
  • 3Braunwald E, Antman EM, Beasley JW. et al. ACC/AHA guide-line update for the management of patients with unstable anginaand non-ST-segment elevation myocardial infarction 2002 : sum-mary article[J]. Circulation,2002,106(14) : 1893-1900.
  • 4柯元南,陈纪林.不稳定性心绞痛和非ST段抬高心肌梗死诊断与治疗指南[J].中华心血管病杂志,2007,35(4):295-304. 被引量：2165
  • 5Wright RS, Anderson JL, Adams CD,et al. 2011 ACCF/AHA fo-cused update of the guidelines for the management of patientswith unstable angina/non-ST-elevation myocardial infarction[J].Circulation,2011,123(18) :2022-2060.
  • 6Pearson TA ,Mensah GA, Alexander RW,et al. Markers of inflamma-tion and cardiovascular disease : application to clinical and public healthpractice : A statement for healthcare professionals from the Centers forDisease Control and Prevention and the American Heart Association[J]. Circulation,2003,107(3) :499-511.
  • 7Potsch AA, Siqueira Filho AG’Tura BR, et al. C-reactive proteindiagnostic and prognostic value in patients presenting at the emer-gency room with chest pain[J], Arq Bras Cardiol,2006,87 ( 3):275-280.
  • 8Lagrand WK, Niessen HW, Wolbink GJ,et al. C-reactive proteincolocalizes with complement in human hearts during acute myo-cardial infarction[J]. Circulation, 1997,95(1) :97-103.

二级参考文献24

  • 1李小鹰.阿司匹林在动脉硬化性心血管疾病中的临床应用:中国专家共识(2005)[J].中华心血管病杂志,2006,34(3):281-284. 被引量：194
  • 2Braunwald E, Antman EM, Beasley JW, et al. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-summary article: a report of the American College of Cardiology/American Heart Association task force on practice guidelines(Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol,2002, 40(7) :1366-1374.
  • 3Bertrand ME, Simoons ML, Fox KA, et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J,2002,23 ( 23 ) : 1809 -1840.
  • 4Erhardt L, Herlitz J, Bossaert L, et al. Task force on the management of chest pain. Eur Heart J, 2002, 23 ( 15 ) : 1153-1176.
  • 5CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet, 1996, 348(9038) :1329-1339.
  • 6Yusuf S, Zhao F, Mehta SR, et al. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med, 2001 , 345 ( 7 ) :494-502.
  • 7Mehta SR, Yusuf S, Peters RJ, et al. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet, 2001, 358(9281):527-533.
  • 8Simoons ML, GUSTO IV-ACS Investigators. Effect of glycopmtein Ⅱb/Ⅲa receptor blocker abciximab on outcome in patients with acute coronary syndromes without early coronary revascularisation:the GUSTO IV-ACS randomised trial. Lancet, 2001,357(9272) :1915-1924.
  • 9Platlat Receptor Inhibitor in Ischemic Syndrome Management(PRISM) study investigator. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina. Platelet Receptor Inhibition in Ischemic Syndrome Management ( PRISM )Study Investigators. N Engl J Med, 1998, 338(21 ) :1498-1505.
  • 10Platlat Receptor Inhibitor in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms(PRISM-PLUS) study investigator. Inhibition of the platelet giycoprotein Ⅱb/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction. Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators. N Engl J Med,1998, 338(21) :1488-1497.

共引文献2164

同被引文献10

引证文献1

二级引证文献29

国际检验医学杂志
2014年 第20期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部